TORONTO--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that the company plans to issue its first quarter 2022 financial results prior to
Flora Growth begins implementing the first cannabinoids produced from Flora’s 254-acre Cosechemos outdoor cultivation facility in Colombia into the Company’s global suite of CPG brands The cannabinoid derivatives were extracted onsite at Cosechemo
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today ann
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI” or the “Company”) will hold a conference call on Wednesday, May 11, 2022, at 8:00am EDT to discuss its results for the three-months ending March 31, 2022. A news r
VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced, in conjunction with its Asia Pacific partner BeiGene, the acceptan
New Facility Creates Renewable Natural Gas (RNG) from Food Waste Diverted from Landfills BURLINGTON, Ontario & PONTINIA, Italy--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced it officially commissioned its Easy
Comprehensive library contains 675 compound entries FRAMINGHAM, Mass.--(BUSINESS WIRE)--#EL--SCIEX, a global leader in life science analytical technologies, in collaboration with Pall Corporation, a global leader in filtration, separation and purificatio
VANCOUVER, British Columbia--(BUSINESS WIRE)--Serenity Bioworks announces today it has completed the acquisition of DC-TAB, a recombinant human HspB5 that was previously in clinical development for relapse-remitting multiple sclerosis. Included in the tra
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases, today announced that Stéphane Paquette, Vice Pr
VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL #AbCellera--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2022, in Toronto, Ca
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Canadian health officials on Tuesday authorized Moderna's (MRNA.O) COVID-19 vaccine targeting the Omicron subvariant, urging all Canadians over the age of six months to get fresh inoculations as the nation sees an uptick in infections.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.